SSII
SS Innovations International, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$3.41
+0.59%Year over year
Reported trailing growth
- Revenue
- +108.5%
- EBITDA
- +57.5%
- EBIT
- +49.0%
- EPS
- +42.2%
- Free cash flow
- -21.7%
- Operating cash flow
- -1.1%
Forward estimates
Based on analyst estimates
- Revenue
- +28.7%
- EBITDA
- +10.4%
- EPS
- +38.7%
Three-year CAGR
- Revenue
- +207.7%
- EBITDA
- +66.3%
- EBIT
- +56.8%
- Net income
- +36.7%
- EPS
- +42.0%
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026